{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:34:35Z","timestamp":1786988075979,"version":"build-2736575974"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"publisher","award":["219Z128"],"award-info":[{"award-number":["219Z128"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejmech.2025.117986","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T15:10:46Z","timestamp":1753283446000},"page":"117986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Multitarget-directed carbamate and carbamothioate derivatives: Cholinesterase and monoamine oxidase inhibition, anti-\u03b2-amyloid (A\u03b2) aggregation, antioxidant and blood\u2013brain barrier permeation properties against Alzheimer's disease"],"prefix":"10.1016","volume":"298","author":[{"given":"Senel","family":"Teke Tuncel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sule","family":"Erol Gunal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130lke","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130pek","family":"Baysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safiye Sag","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6k\u00e7en","family":"Telli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulberk","family":"Ucar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilknur","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrin Gokhan","family":"Kelekci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117986_bib1","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/S0140-6736(17)32399-1","article-title":"Why do so many clinical trials of therapies for Alzheimer's disease fail?","volume":"390","author":"Anderson","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.117986_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12929-017-0355-7","article-title":"Drug candidates in clinical trials for Alzheimer's disease","volume":"24","author":"Hung","year":"2017","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ejmech.2025.117986_bib3","doi-asserted-by":"crossref","DOI":"10.1006\/exnr.2000.7397","article-title":"On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis","volume":"163","author":"Bartus","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejmech.2025.117986_bib4","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/molecules27061816","article-title":"Role of cholinergic signaling in alzheimer's disease","volume":"27","author":"Chen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117986_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S0306-4522(01)00613-3","article-title":"Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine","volume":"110","author":"Mesulam","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2025.117986_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134804","article-title":"Discovery of carbamate-based salicylic acid derivatives as novel cholinesterase inhibitor","volume":"1276","author":"Wang","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117986_bib7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/bj2600625","article-title":"Comparison of butyrylcholinesterase and acetylcholinesterase","volume":"260","author":"Chatonnet","year":"1989","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2025.117986_bib8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0301-0082(99)00047-7","article-title":"The key role of butyrylcholinesterase during neurogenesis and neural disorders: an antisense-5'butyrylcholinesterase-DNA study","volume":"60","author":"Mack","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejmech.2025.117986_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2990.1978.tb00545.x","article-title":"Changes in brain cholinesterases in senile dementia of alzheimer type","volume":"4","author":"Perry","year":"1978","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.ejmech.2025.117986_bib10","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","article-title":"Selective loss of central cholinergic neurons in alzheimer \u2019s disease","volume":"2","author":"Davies","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.117986_bib11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2174\/156720512799015127","article-title":"Biochemical differentiation of cholinesterases from normal and alzheimer's disease cortex","volume":"9","author":"Ciro","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejmech.2025.117986_bib12","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/gps.935","article-title":"Cholinergic function and alzheimer's disease","volume":"18","author":"Giacobini","year":"2003","journal-title":"Int. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.ejmech.2025.117986_bib13","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers alzheimer \u03b2-Amyloid peptide in rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2025.117986_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/srep39495","article-title":"Development of an In-Vivo active reversible butyrylcholinesterase inhibitor","volume":"6","author":"Ko\u0161ak","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117986_bib15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bbr.2011.07.035","article-title":"Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by Amyloid-\u03b2 peptide in mice","volume":"225","author":"Furukawa-Hibi","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2025.117986_bib16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1471-4159.2006.04347.x","article-title":"Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity","volume":"100","author":"Hartmann","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2025.117986_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.137841","article-title":"Pristine 2-chloroquinoline-based-thiosemicarbazones as multitarget agents against alzheimer's disease: in vitro and in silico studies of monoamine oxidase (MAO) and cholinesterase (ChE) inhibitors","volume":"1306","author":"Jalil","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117986_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2024.111407","article-title":"Coptisine reverses Alzheimer's disease by targeting cholinergic and amyloidogenic pathways","volume":"189","author":"Roy","year":"2024","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ejmech.2025.117986_bib19","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1016\/j.bmcl.2010.04.059","article-title":"Synthesis and binding ability of 1,2,3-triazole-based triterpenoid receptors for recognition of Hg(2\u00fe) ion","volume":"20","author":"Yu","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117986_bib20","first-page":"2895","article-title":"Organic carbamates in drug design and medicinal chemistry\u0130 Med","volume":"58","author":"Ghosh","year":"2015","journal-title":"Chem"},{"key":"10.1016\/j.ejmech.2025.117986_bib21","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3390\/molecules25040884","article-title":"Newly developed prodrugs and prodrugs in development; an insight of the recent years","volume":"25","author":"Najjar","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117986_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116071","article-title":"Design, synthesis and biological evaluation of carbamate derivatives incorporating multifunctional carrier scaffolds as pseudo-irreversible cholinesterase inhibitors for the treatment of Alzheimer's disease","volume":"265","author":"Liu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114606","article-title":"Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease","volume":"240","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106977","article-title":"Panaxadiol carbamate derivatives: synthesis and biological evaluation as potential multifunctional anti-alzheimer agents","volume":"143","author":"Quan","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128574","article-title":"Development of naringenin-O-carbamate derivatives as multi-target-directed liagnds for the treatment of Alzheimer's disease","volume":"60","author":"Mi","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117986_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114044","article-title":"Design, synthesis, and biological evaluation of carbamate derivatives of N-Salicyloyl tryptamine as multifunctional agents for the treatment of Alzheimer's disease","volume":"229","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116646","article-title":"Design, synthesis and evaluation of carbamate-bridged amino acid prodrugs of cycloicaritin with improved antitumor activity, aqueous solubility and phase II metabolic stability","volume":"276","author":"Wang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.142451","article-title":"Design and synthesis of novel carbamate derivatives as cholinesterase inhibitors for the treatment of Alzheimer's disease: bioassay and molecular dynamics","volume":"1339","author":"Mohammadi","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117986_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105993","article-title":"Discovery of carbamate-based N-salicyloyl tryptamine derivatives as novel pleiotropic agents for the treatment of Alzheimer's disease","volume":"127","author":"Wang","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib30","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1016\/j.bmc.2014.06.010","article-title":"Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase","volume":"22","author":"Darras","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117003","article-title":"Natural phenol carbamates: selective BuChE\/FAAH dual inhibitors show neuroprotection in an Alzheimer's disease mouse model","volume":"281","author":"Rong","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.129787","article-title":"Design, synthesis, and biological evaluation of novel indanone-based hybrids as multifunctional cholinesterase inhibitors for Alzheimer's disease","volume":"1229","author":"Shahrivar-Gargari","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117986_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113735","article-title":"Novel cannabidiol carbamate hybrids as selective BuChE inhibitors: docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease","volume":"223","author":"Jiang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105844","article-title":"Carbamate-based N-Substituted tryptamine derivatives as novel pleiotropic molecules for Alzheimer's disease","volume":"125","author":"Zhang","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib35","article-title":"Novel AP2238-clorgiline hybrids as multi-target agents for the treatment of Alzheimer's disease: design, synthesis, and biological evaluation","volume":"130","author":"He","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib36","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00702-013-1027-8","article-title":"Computational modeling of the direct hydride transfer mechanism for the MAO catalyzed oxidation of phenethylamine and benzylamine: ONIOM (QM\/QM) calculations","volume":"120","author":"Aky\u00fcz","year":"2013","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejmech.2025.117986_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105724","article-title":"HDAC1\/MAO-B dual inhibitors against Alzheimer's disease: design, synthesis and biological evaluation of N-propargylamine-hydroxamic acid\/o-aminobenzamide hybrids","volume":"122","author":"Yao","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115550","article-title":"Rational design, synthesis and biological evaluation of novel multitargeting anti-AD iron chelators with potent MAO-B inhibitory and antioxidant activity","volume":"28","author":"Jiang","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107152","article-title":"A comprehensive review of multi-target directed ligands in the treatment of Alzheimer's disease","volume":"144","author":"Pathak","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105941","article-title":"Rational drug design strategies for the development of promising multi-target directed indole hybrids as Anti-Alzheimer agents","volume":"127","author":"George","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116511","article-title":"Structure-based design of multitargeting ChEs-MAO B inhibitors based on phenyl ring bioisosteres: AChE\/BChE selectivity switch and drug-like characterization","volume":"274","author":"Spada","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib42","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.bioorg.2018.02.003","article-title":"Asymmetric synthesis, molecular modeling and biological evaluation of 5-methyl-3-aryloxazolidine-2,4-dione enantiomers as monoamine oxidase (MAO) inhibitors","volume":"77","author":"Erol Gunal","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib43","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.neuropharm.2016.06.013","article-title":"Design, synthesis and evaluation of novel dual monoamine cholinesterase inhibitors as potential treatment for Alzheimer's disease","volume":"109","author":"Liu","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2025.117986_bib44","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.molstruc.2014.07.063","article-title":"Conformation analysis and computation of energy barrier to rotation about CAN bond in para-methylphenyl carbamate and its solvent dependence in comparison with tertiary carbamates and tertiary amides","volume":"1076","author":"Modarresi-Alam","year":"2014","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117986_bib45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.molstruc.2018.10.055","article-title":"Thioureas and their cyclized derivatives: synthesis, conformational analysis and antimicrobial evaluation","volume":"1179","author":"Teke Tuncel","year":"2019","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117986_bib46","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1139\/v98-083","article-title":"The conformational equilibrium of N,N'-bis[(S)-1-phenylethyl]-thiourea and its solvent dependence, studied by NMR and CD spectra and by X-Ray crystallography","volume":"76","author":"Rang","year":"1998","journal-title":"Can. J. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib47","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib48","series-title":"Monoamine Oxidase. Methods in Molecular Biology","first-page":"2558","article-title":"Computational chemistry and molecular modeling of reversible MAO inhibitors","author":"Yelek\u00e7i","year":"2023"},{"key":"10.1016\/j.ejmech.2025.117986_bib49","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00702-012-0950-4","article-title":"Insights into the binding mode of new N-Substituted pyrazoline derivatives to MAO-A: docking and quantum chemical calculations","volume":"120","author":"Erdem","year":"2013","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejmech.2025.117986_bib50","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ecoenv.2018.11.099","article-title":"Revisiting fish toxicity of active pharmaceutical ingredients: mechanistic insights from integrated ligand-\/structure-based assessments on acetylcholinesterase","volume":"170","author":"Minovski","year":"2019","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.ejmech.2025.117986_bib51","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/molecules21020191","article-title":"Novel cholinesterase inhibitors based on O-aromatic N, N-disubstituted carbamates and thiocarbamates","volume":"21","author":"Kr\u00e1tk\u00fd","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117986_bib52","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.3390\/molecules22122098","article-title":"Comparison of the binding of reversible inhibitors to human butyrylcholinesterase and acetylcholinesterase: a crystallographic, kinetic and calorimetric study","volume":"22","author":"Rosenberry","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117986_bib53","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.1021\/bi051847g","article-title":"Functional role of the \u2018\u2018aromatic cage\u2019\u2019 in human monoamine oxidase B: structures and catalytic properties of Tyr435 mutant proteins","volume":"45","author":"Li","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.117986_bib54","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00702-007-0670-3","article-title":"The aromatic cage in the active site of monoamine oxidase B: effect on the structural and electronic properties of bound benzylamine and p-nitrobenzylamine","volume":"114","author":"Aky\u00fcz","year":"2007","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejmech.2025.117986_bib55","doi-asserted-by":"crossref","first-page":"12292","DOI":"10.1021\/acs.jmedchem.2c01003","article-title":"Discovery of potent cholinesterase inhibition-based multi-target-directed lead compounds for synaptoprotection in Alzheimer's disease","volume":"65","author":"Turgutalp","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib56","doi-asserted-by":"crossref","first-page":"12684","DOI":"10.1073\/pnas.0505975102","article-title":"Three-dimensional structure of human monoamine oxidase A (MAOA): relation to the structures of rat MAO A and human MAO B","volume":"102","author":"Colibus","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2025.117986_bib57","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s11224-022-02092-x","article-title":"In vitro and in silico investigation of inhibitory activities of 3-arylcoumarins and 3-phenylazo-4-hydroxycoumarin on MAO isoenzymes","volume":"34","author":"Yuce-Dursun","year":"2023","journal-title":"Struct. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib58","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib59","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: a force field for drug\u2010like molecules compatible with the CHARMM all\u2010atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-009-8104-z","article-title":"An overview of APP processing enzymes and products","volume":"12","author":"Chow","year":"2010","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.ejmech.2025.117986_bib61","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.R800019200","article-title":"Amyloid precursor protein trafficking, processing, and function","volume":"283","author":"Thinakaran","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib62","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-4939-2074-7_5","article-title":"Culture and functional characterization of human hepatoma HepG2 cells","volume":"1250","author":"Donato","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.117986_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.107010","article-title":"Design, synthesis, and biological evaluation of novel donepezil-tacrine hybrids as multi-functional agents with low neurotoxicity against Alzheimer's disease","volume":"143","author":"Wang","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib64","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib65","doi-asserted-by":"crossref","DOI":"10.4172\/jbb.S14-009","article-title":"Optimization and validation of an in vitro blood brain barrier permeability assay using artificial lipid membrane","volume":"S14","author":"Jhala","year":"2012","journal-title":"J. Bioequivalence Bioavailab."},{"key":"10.1016\/j.ejmech.2025.117986_bib66","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1021\/ci500467k","article-title":"iLOGP: a simple, robust, and efficient description of n-octanol\/water partition coefficient for drug design using the GB\/SA approach","volume":"54","author":"Daina","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.117986_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117986_bib68","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2025.117986_bib69","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.bmcl.2010.01.035","article-title":"Design, synthesis and evaluation of carbamate-modified (-)-N(1)-phenethylnorphysostigmine derivatives as selective butyrylcholinesterase inhibitors","volume":"20","author":"Takahashi","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117986_bib70","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117986_bib71","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0003-2697(02)00506-7","article-title":"Molar absorption coefficients for the reduced Ellman reagent: reassessment","volume":"312","author":"Eyer","year":"2003","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2025.117986_bib72","doi-asserted-by":"crossref","first-page":"W441","DOI":"10.1093\/nar\/gkp253","article-title":"IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding","volume":"37","author":"Cer","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.117986_bib73","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2025.117986_bib74","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00702-016-1527-4","article-title":"Donepezil loaded PLGA-b-PEG nanoparticles: their ability to induce destabilization of amyloid fibrils and to cross blood brain barrier in vitro","volume":"124","author":"Baysal","year":"2017","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejmech.2025.117986_bib75","doi-asserted-by":"crossref","first-page":"15514","DOI":"10.1021\/bi991161m","article-title":"Interaction between A beta(1-42) and A beta(1-40) in Alzheimer's beta-amyloid fibril formation in vitro","volume":"38","author":"Hasegawa","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.117986_bib76","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1021\/jf000220w","article-title":"Assessing antioxidant and prooxidant activities of phenolic compounds","volume":"48","author":"Fukumoto","year":"2000","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib77","doi-asserted-by":"crossref","first-page":"7970","DOI":"10.1021\/jf048741x","article-title":"Novel total antioxidant capacity index for dietary polyphenols and vitamins C and E, using their cupric ion reducing capability in the presence of neocuproine: CUPRAC method","volume":"52","author":"Apak","year":"2004","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2025.117986_bib78","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0024-3205(97)00004-0","article-title":"Free radical scavenging activity of mushroom polysaccharide extracts","volume":"60","author":"Liu","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2025.117986_bib79","article-title":"Cell proliferation and cytotoxicity assays, the fundamentals for drug discovery","volume":"3","author":"Niu","year":"2024","journal-title":"Int. J. Drug Discov. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117986_bib80","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1134\/S106235902360455X","article-title":"Methylene blue attenuates impaired cognitive functions and reduces hippocampal A\u03b2 levels and oxidative stress in D-Galactose-Induced Alzheimer's disease mouse model","volume":"51","author":"Kazkayas\u0131","year":"2024","journal-title":"Biol. Bull."},{"key":"10.1016\/j.ejmech.2025.117986_bib81","first-page":"188","article-title":"Possible neuroprotective role of pomegranate juice in aluminum chloride induced alzheimer's like disease in mice","volume":"5","author":"Abdulmalek","year":"2015","journal-title":"Alzheimers Dis. Parkinsonism."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425007512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425007512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:40:57Z","timestamp":1772772057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425007512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":81,"alternative-id":["S0223523425007512"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117986","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multitarget-directed carbamate and carbamothioate derivatives: Cholinesterase and monoamine oxidase inhibition, anti-\u03b2-amyloid (A\u03b2) aggregation, antioxidant and blood\u2013brain barrier permeation properties against Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117986"}}